Balamoola rasayana for sciatica

An open labelled randomized controlled clinical study to evaluate the effect of vardhamana balamoola rasayana in gridhrasi w.s.r to sciatica syndrome. - Nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/03/064609

Enrollment

Registered

2024-03-21

Start date

Unknown

Completion date

Unknown

Last updated

2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M543- Sciatica

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients fulfilling the diagnostic criteria. 2.Patients with or without radiological evidence-MRI,CT of disc prolapse. 3.Patients with or without radiological evidence-MRI,CT of lumbar spondylosis. 4.Patients between the age groups of 18-70 years and of either sex.

Exclusion criteria

Exclusion criteria: 1.Patients with radiological evidence of fracture of vertebrae, congenital deformities and neoplasm of spine. 2.Pregnancy and lactating mother. 3.Evidence of osteoporosis with BMD less than -2.5 4.Had participated in any clinical trial within 3 months of screening.

Design outcomes

Primary

Measure	Time frame
changes in the signs and symptoms of gridrasi. changes in VAS scale improvement on the basis of SLR test,bregards test, lasegues sign,bowstring test,femoral nerve stretch test,flip test improvement in objective parameters like pain-greenough and fraser scoring method,neurological deficit assessment,assessment of functional ability-sugarbaker and barofsky clinical mobility scale,functional disability assessment-oswestry disability assessment questionnaireTimepoint: group A- 48 days group B-61 days	—

Measure

Time frame

changes in the signs and symptoms of gridrasi. changes in VAS scale improvement on the basis of SLR test,bregards test, lasegues sign,bowstring test,femoral nerve stretch test,flip test improvement in objective parameters like pain-greenough and fraser scoring method,neurological deficit assessment,assessment of functional ability-sugarbaker and barofsky clinical mobility scale,functional disability assessment-oswestry disability assessment questionnaireTimepoint: group A- 48 days group B-61 days

—

Secondary

Measure	Time frame
objective parametersTimepoint: 2 weeks	—

Countries

India

Contacts

Public ContactDr. Anchumol Joseph

SDM Ayurveda medical college and hospital kuthpady,udupi

anisaralaya@gmail.com9446529173

Outcome results